Valganciclovir for cytomegalovirus viraemia in advanced HIV disease: a phase 2b randomized placebo-controlled trial of valganciclovir for cytomegalovirus viraemia in adults and adolescents with advanced HIV disease
Philosophical Transactions of the Royal Society B: Biological Sciences · 2025
DOI: 10.1098/rstb.2024.0402 ↗Kurz gefasst
Fachartikel in der Zeitschrift Philosophical Transactions of the Royal Society B: Biological Sciences, 2025. Verfasst von Jayne Ellis und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK. Hauptthemen laut MEDLINE: Antiviral Agents, Cytomegalovirus, Cytomegalovirus Infections, HIV Infections. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIH HHS, Medical Research Council.
Abstract (Originalsprache)
Mortality among adults hospitalized with advanced HIV disease (AHD; CD4 20%; there is an urgent need to evaluate strategies to reduce mortality within this extremely high-risk group. Approximately 50% of adults with CD4 counts
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Research, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
- Infectious Diseases Institute, Makerere University, Kampala, Uganda.
- Clinical HIV Research Unit, a division of the Wits Health Consortium, Helen Joseph Hospital, Johannesburg 2193, South Africa.
- Botswana Harvard Health Partnership, Gaborone, Botswana.
- School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
- Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
ORCID-Profile: Jayne Ellis
Förderung
- NINDS NIH HHS
- NIH HHS
- Medical Research Council
- NIH
Zitieren
APA
Ellis, J., Nsangi, L. J., Rassool, M., Musaazi, J., Lawrence, D. S., Skipper, C., Boulware, D. R., Meya, D. B., Wasserman, S., Jarvis, J. N., & Boyles, T. (2025). Valganciclovir for cytomegalovirus viraemia in advanced HIV disease: a phase 2b randomized placebo-controlled trial of valganciclovir for cytomegalovirus viraemia in adults and adolescents with advanced HIV disease. Philosophical Transactions of the Royal Society B: Biological Sciences. https://doi.org/10.1098/rstb.2024.0402
Vancouver
Ellis J, Nsangi LJ, Rassool M, Musaazi J, Lawrence DS, Skipper C, et al. Valganciclovir for cytomegalovirus viraemia in advanced HIV disease: a phase 2b randomized placebo-controlled trial of valganciclovir for cytomegalovirus viraemia in adults and adolescents with advanced HIV disease. Philosophical Transactions of the Royal Society B: Biological Sciences. 2025. doi:10.1098/rstb.2024.0402
BibTeX
@article{Ellis2025,
author = {Ellis, Jayne and Nsangi, Laura Joan and Rassool, Mohammed and Musaazi, Joseph and Lawrence, David S and Skipper, Caleb and Boulware, David R and Meya, David B and Wasserman, Sean and Jarvis, Joseph N and Boyles, Tom},
title = {Valganciclovir for cytomegalovirus viraemia in advanced HIV disease: a phase 2b randomized placebo-controlled trial of valganciclovir for cytomegalovirus viraemia in adults and adolescents with advanced HIV disease},
journal = {Philosophical Transactions of the Royal Society B: Biological Sciences},
year = {2025},
doi = {10.1098/rstb.2024.0402}
}
EUVIMED